The LATAM Media Report
SEE OTHER BRANDS

Your media and advertising news from Latin America

The LATAM Media Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.

Press releases published on April 30, 2025

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …

BioAtla to Participate in the Citizens Life Sciences Conference

BioAtla to Participate in the Citizens Life Sciences Conference

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today …

EDR Killers: What They Are, Why They Matter, and How Organizations Can Stay Protected

EDR Killers: What They Are, Why They Matter, and How Organizations Can Stay Protected

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, is warning organizations to stay alert as “EDR killers” - tools designed to disable Endpoint Detection and Response (EDR) solutions- grow more accessible and more widely …

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

DUBLIN, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a. …

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences: Event: BofA …

Solid Biosciences to Participate at The Citizens Life Sciences Conference

Solid Biosciences to Participate at The Citizens Life Sciences Conference

CHARLESTOWN, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, announced that Bo Cumbo, …

IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Frank R. Hallam, CEO of Platinum Group Metals Ltd.

IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Frank R. Hallam, CEO of Platinum Group Metals Ltd.

AUSTIN, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The MiningNewsWire …

Valitor to Present on its Drug Candidate with Twice-Yearly Dosing for Wet AMD at the American Academy of Ophthalmology’s Eyecelerator Conference and the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Valitor to Present on its Drug Candidate with Twice-Yearly Dosing for Wet AMD at the American Academy of Ophthalmology’s Eyecelerator Conference and the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

BERKELEY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced its president and chief scientific officer, Wesley Jackson, Ph.D., will present a company and …

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …

Global-e to Announce Financial Results for the First Quarter 2025 on May 14, 2025

Global-e to Announce Financial Results for the First Quarter 2025 on May 14, 2025

PETAH-TIKVA, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the first quarter ended March 31, 2025, before …

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York

WEST CHESTER, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced …

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress

NAARDEN, the Netherlands and MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …

authID to Report First Quarter 2025 Financial Results on May 13, 2025

authID to Report First Quarter 2025 Financial Results on May 13, 2025

DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID”), a leading provider of biometric identity verification and authentication solutions, today announced the Company will report financial results for the first quarter ended March 31 …

Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025

Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025

CHICAGO and FORT WORTH, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …

Indonesia Energy Files 2024 Annual Report and Provides an Update on Operations and Planned Drilling During the Remainder of 2025

Indonesia Energy Files 2024 Annual Report and Provides an Update on Operations and Planned Drilling During the Remainder of 2025

2024 investments in seismic and other exploration work at Kruh Block set the stage for new drilling in the second half of 2025 JAKARTA, INDONESIA AND DANVILLE, CA, April 30, 2025 (GLOBE NEWSWIRE) -- Indonesia Energy Corporation (NYSE American: INDO) ("IEC …

INNEOVA Holdings Limited Strengthens Engineering Capabilities and Accelerates Growth in Sustainable Solutions with the Acquisition of INNEOVA Engineering Pte. Ltd.

INNEOVA Holdings Limited Strengthens Engineering Capabilities and Accelerates Growth in Sustainable Solutions with the Acquisition of INNEOVA Engineering Pte. Ltd.

SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- INNEOVA Holdings Limited (Nasdaq: INEO, "INNEOVA Holdings" or the "Company" or the "Group"), a leading Singapore-based provider of high-quality Original Equipment Manufacturer ("OEM"), third-party branded and …

Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

BETHESDA, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

Charging Robotics Installs Wireless EV Charging System in Automatic Parking Facility

Charging Robotics Installs Wireless EV Charging System in Automatic Parking Facility

Pioneering seamless EV charging experience for robotic parking systems Tel Aviv, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Charging Robotics Inc. (OTC: CHEV), a leading innovator in wireless electric vehicle (EV) charging solutions, announces that it has …

Jeffs’ Brands Enters Into a Definitive Agreement to Sell Key U.S. Assets to a Canadian Public Company for an Approximate Valuation of $11.8 Million

Jeffs’ Brands Enters Into a Definitive Agreement to Sell Key U.S. Assets to a Canadian Public Company for an Approximate Valuation of $11.8 Million

The transaction includes the acquisition of Jeffs’ Brands’ wholly-owned subsidiary, Smart Repair Pro, and its approximately 49.1% ownership interest in SciSparc Nutraceutical Inc. by a Canadian public company in exchange for an up to 90% equity interest ( …

Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting

Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting

Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin  Data supports ongoing Phase 1 clinical trial for CT-95   PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service